- Home
- EPC vs BLFS Comparison
EPC vs BLFS Comparison
Compare EPC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPC
- BLFS
- Stock Information
- Founded
- EPC 1999
- BLFS 1987
- Country
- EPC United States
- BLFS United States
- Employees
- EPC N/A
- BLFS N/A
- Industry
- EPC Package Goods/Cosmetics
- BLFS Medical/Dental Instruments
- Sector
- EPC Consumer Discretionary
- BLFS Health Care
- Exchange
- EPC Nasdaq
- BLFS Nasdaq
- Market Cap
- EPC 1.4B
- BLFS 1.3B
- IPO Year
- EPC 2000
- BLFS 1989
- Fundamental
- Price
- EPC $19.72
- BLFS $28.87
- Analyst Decision
- EPC Buy
- BLFS Strong Buy
- Analyst Count
- EPC 6
- BLFS 7
- Target Price
- EPC $26.33
- BLFS $30.86
- AVG Volume (30 Days)
- EPC 542.6K
- BLFS 371.2K
- Earning Date
- EPC 11-13-2025
- BLFS 11-06-2025
- Dividend Yield
- EPC 3.05%
- BLFS N/A
- EPS Growth
- EPC N/A
- BLFS N/A
- EPS
- EPC 1.34
- BLFS N/A
- Revenue
- EPC $2,203,900,000.00
- BLFS $93,468,000.00
- Revenue This Year
- EPC N/A
- BLFS $25.65
- Revenue Next Year
- EPC $2.18
- BLFS $14.81
- P/E Ratio
- EPC $14.69
- BLFS N/A
- Revenue Growth
- EPC N/A
- BLFS 68.16
- 52 Week Low
- EPC $19.13
- BLFS $19.10
- 52 Week High
- EPC $38.45
- BLFS $29.57
- Technical
- Relative Strength Index (RSI)
- EPC 39.17
- BLFS 65.07
- Support Level
- EPC $19.50
- BLFS $26.74
- Resistance Level
- EPC $20.30
- BLFS $28.56
- Average True Range (ATR)
- EPC 0.50
- BLFS 1.07
- MACD
- EPC 0.08
- BLFS 0.09
- Stochastic Oscillator
- EPC 23.17
- BLFS 82.19
About EPC Edgewell Personal Care Company
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.